They've identified which grants wouldn't have been funded had similar cuts been made earlier in this century and tracked the ...

Applied Therapeutics has yet to confirm whether the study, posted on Clinicaltrials.gov on Friday, means it has indeed ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

The NHS must pay more towards new drug development to help cut prices for Americans, a major US pharmaceutical giant has said ...

In 2022, the US National Institutes of Health (NIH) awarded Chanda an Antiviral Drug Discovery (AViDD) grant that provided ...

Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and ...

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

Analysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid ...

Kala Bio will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the drug developer's shares down 93% in ...